Evidence map›Paper›PMID 28491224›Full record

ArticleThe Pan African medical journal2017

[Macrophage activation syndrome complicating family lymphohistiocytosis].

Yousra El Boussaadni, Noufissa Benajiba, Ahmed Aziz Bousfiha, Fatima Ailal

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Yousra El BoussaadniService de Pédiatrie, CHU Mohamed VI, Université Mohamed Premier, Oujda.
Noufissa BenajibaService de Pédiatrie, CHU Mohamed VI, Université Mohamed Premier, Oujda.
Ahmed Aziz BousfihaService d'Immunologie Clinique, Hôpital d'Enfants de Casablanca, CHU Ibn Rochd, Univesité Hassan II.
Fatima AilalService d'Immunologie Clinique, Hôpital d'Enfants de Casablanca, CHU Ibn Rochd, Univesité Hassan II.
Mohamed I University · MACentre Hospitalier Universitaire Hassan II · MAHôpital d'Enfants · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage activation syndrome (MAS) is an anatomoclinic entity due to inappropriate macrophage activation. It is a rare pathology, characterized by clinical signs that are not very specific and by biological elements. Their association must evoke the diagnosis. It can be classified as primary or secondary, its prognosis is still unclear. We report the case of a 3-year and 4-month-old infant admitted to our department with primary MAS in order to remind clinicians the importance of suspecting primary cause in specific situations.

Indexed as

Child, PreschoolFemaleHumansLymphohistiocytosis, HemophagocyticMacrophage Activation SyndromePrognosisfamilial lymphohistiocytosisfevergenetic studyMacrophage activation syndrome

Identifiers

PMID28491224
PMCPMC5410000
OpenAlexW2594774803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.